title: Autoantibodies in cryptogenic fibrosing alveolitis.
abstract: The pathogenesis of cryptogenic fibrosing alveolitis (CFA) involves injury, an immune/inflammatory response and fibrosis. The cause of the injury is unknown, but the identification of serum autoantibodies makes an autoimmune aetiology attractive. The core study on which this commentary is based used novel cloning and serum screening technologies in order to identify new public and private autoantibodies in sera from 12 patients with CFA. Largely negative conclusions were drawn from that study. However, we suggest that the prevalence of autoantibodies may have been underestimated, that the study was timely and that this approach is worth pursuing further.
authors.affiliation: Royal Brompton Hospital, Sydney Street, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: Singh
authors.forename: R
authors.initials: R
authors.lastname: du Bois
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D006801:Humans; D011658:Pulmonary Fibrosis / Q000453:epidemiology / Q000209:etiology / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
chemical_list: D001323:Autoantibodies